Peregrine Pharmaceuticals reported $51.1M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
AstraZeneca AZN:LN 39268M 476M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Immunogen IMGN:US $ 306.47M 19.12M
Intrexon XON:US $ 131.25M 27.95M
Minerva Neurosciences NERV:US $ -0.74M 8.71M
Newlink Genetics NLNK:US $ 81.82M 7.16M
Novartis NOVN:VX SF 67655M 10884M
Peregrine Pharmaceuticals PPHM:US $ 51.1M 6.47M
Xencor XNCR:US $ 763.02M 29.52M